HMG
Human Menopausal Gonadotropin / Menopur / Pergonal
Human Menopausal Gonadotropin (HMG) is a urinary-derived preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in approximately equal proportions, extracted and purified from the urine of postmenopausal women. It is FDA-approved for the treatment of infertility in both men and women, stimulating follicular development in women and spermatogenesis in men. Brand names include Menopur and Pergonal, and it remains a cornerstone of assisted reproductive technology.
Wirkmechanismus
Combination of FSH and LH extracted from post-menopausal urine. Directly stimulates ovarian follicular development (FSH component) and supports ovulation and corpus luteum function (LH component). Used in assisted reproduction protocols.
Forschungsprotokolle
Nur für Forschungszwecke. Keine medizinische Beratung.
Fertility protocols use 75-150 IU daily via intramuscular injection, adjusted based on ovarian response monitoring. Male protocols for spermatogenesis use 75-150 IU 2-3 times weekly with HCG.
Forschungsnotizen
Clinical Research Status
HMG has been used in fertility medicine since the 1960s and holds FDA approval for ovulation induction in women with anovulatory infertility and for spermatogenesis stimulation in men with hypogonadotropic hypogonadism. Highly purified urinary HMG (Menopur) and recombinant alternatives (Gonal-F for FSH, Luveris for LH) provide different formulation options. Ongoing research compares urinary-derived versus recombinant gonadotropins for IVF outcomes.
Key Published Findings
Clinical trials demonstrate that HMG protocols produce equivalent or slightly superior IVF outcomes compared to recombinant FSH alone, possibly due to the LH component's contribution to follicular steroidogenesis. In male infertility, HMG combined with HCG can restore spermatogenesis in men with gonadotropin deficiency, with sperm appearing in ejaculate typically within 6-18 months. The LH activity in HMG supports theca cell androgen production necessary for optimal follicular development.
Safety Profile
Ovarian hyperstimulation syndrome (OHSS) is the most significant risk, ranging from mild (abdominal bloating) to severe (ascites, thromboembolism), requiring careful ultrasound and estradiol monitoring during stimulation cycles. Multiple pregnancy rates are elevated (15-25% in IUI cycles) due to multi-follicular development. In male patients, adverse effects are generally limited to gynecomastia and acne from increased testosterone and estrogen production.
Comparison to Related Compounds
Unlike recombinant FSH (follitropin alfa/beta), HMG contains both FSH and LH activity, providing a more complete gonadotropin stimulus. Compared to HCG which mimics only LH, HMG provides direct FSH stimulation critical for Sertoli cell function and spermatogenesis initiation. Highly purified HMG (Menopur) contains LH activity primarily from HCG co-purified from urine rather than true LH, though biological activity is equivalent.
Community Observations
Fertility specialists often debate the clinical significance of the LH component in HMG versus pure FSH protocols, with some evidence favoring HMG in specific patient populations (older women, poor responders). In male fertility protocols, HMG is typically added to HCG after initial testosterone normalization to specifically target spermatogenesis. Cost considerations remain relevant as urinary-derived preparations are generally less expensive than recombinant alternatives.
Halbwertszeit
~24-48 hours
Rekonstitution
Sterile diluent provided with kit
Lagerung
Lyophilisiert
Refrigerate 2-8C.
Rekonstituierter
Use immediately after reconstitution.
Rechtsstatus USA
Auch bekannt als
Häufig gestellte Fragen
Was ist HMG?
Human Menopausal Gonadotropin (HMG) is a urinary-derived preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in approximately equal proportions, extracted and purified from the urine of postmenopausal women. It is FDA-approved for the treatment of infertility in both men and women, stimulating follicular development in women and spermatogenesis in men. Brand names include Menopur and Pergonal, and it remains a cornerstone of assisted reproductive technology.
Wie wirkt HMG?
Combination of FSH and LH extracted from post-menopausal urine. Directly stimulates ovarian follicular development (FSH component) and supports ovulation and corpus luteum function (LH component). Used in assisted reproduction protocols.
Wie ist der regulatorische Status von HMG in den USA?
FDA-approved (Rx only)
Wie lang ist die Halbwertszeit von HMG?
~24-48 hours
Wie wird HMG noch genannt?
Human Menopausal Gonadotropin, Menopur, Pergonal
Peptide Contacts bietet wissenschaftliche Zusammenfassungen für informationstechnische Zwecke an. Wir stellen keine Dokumentationen von Anbietern, keine Host- und keine Vertriebsdienstleistungen zur Verfügung und unterstützen keine Anbieter in irgendeiner Weise. Alle Zertifikate der Analyse, GMP-Zertifikate und Kommunikationen mit Anbietern müssen direkt vom Käufer angefordert und überprüft werden. Alles auf dieser Plattform stellt weder rechtliche, medizinische noch berufsmäßige Beratung dar. Nutzer sind allein verantwortlich für die Überprüfung der Anbieterzertifikate und das Gewährleisten des Einhaltens aller anwendbaren lokalen, zuständigen und federalen Gesetze beim Kauf von Forschungschemikalien. Die Nutzung dieser Plattform bedeutet die Annahme volles persönlichen Verantwortlichkeitsbewusstseins.
Ganze Erklärung lesen